Re:GLP-1 drugs led to weight loss and reversed depression-li...
by JumpCrisscross on Saturday June 27, 2026 @10:41PM
(#48703852)
> Third party private healthcare decisions are almost non-existant in the US due to the payment systems
The payment part is almost entirely pushing against GLP-1 agonists. Nobody has a long-term financial stake in patient costs to care that lifetime costs will likely be lower; insurers are just looking at the next couple years against expected churn. Another cost of tying health insurance to employment.
The payment part is almost entirely pushing against GLP-1 agonists. Nobody has a long-term financial stake in patient costs to care that lifetime costs will likely be lower; insurers are just looking at the next couple years against expected churn. Another cost of tying health insurance to employment.